Debra Yu - May 4, 2022 Form 4 Insider Report for LianBio (LIAN)

Role
President & Chief Strategy Officer
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Stock symbol
LIAN
Transactions as of
May 4, 2022
Transactions value $
$1,710,000
Form type
4
Date filed
5/6/2022, 04:15 PM
Previous filing
Apr 27, 2022
Next filing
Jun 12, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIAN Ordinary Shares Options Exercise $1.71M +1M $1.71 1M May 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Options Exercise $0 -1M -50% $0.00 1M May 4, 2022 Ordinary Shares 1M $1.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares underlying the option vested and became exercisable on January 1, 2020; 1/3 of the shares underlying the option vested and became exercisable on October 1, 2020 and 1/3 of the shares underlying the option vested and became exercisable on October 1, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

President & Chief Strategy Officer